GSK has acquired RAPT Therapeutics
Further information can be found in the latest press release.
COMMITTED TO DISCOVERING BEST-IN-CLASS THERAPIES
TO CONQUER INFLAMMATORY and immunologic DISEASES
RAPT Therapeutics Announces Effective Date for 1-for-8 Reverse Stock Split
June 13, 2025
« back to news page
You are leaving RAPT.com to go to the eczema clinical trial study site.
